1-161306707-C-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000530.8(MPZ):c.448+1G>A variant causes a splice donor, intron change. The variant allele was found at a frequency of 0.000000684 in 1,461,696 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000530.8 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- Charcot-Marie-Tooth diseaseInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- Charcot-Marie-Tooth disease type 1BInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Orphanet
- neuropathy, congenital hypomyelinating, 2Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
- autosomal dominant intermediate Charcot-Marie-Tooth disease with neuropathic painInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Charcot-Marie-Tooth disease dominant intermediate DInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Charcot-Marie-Tooth disease type 2IInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Charcot-Marie-Tooth disease type 2JInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Charcot-Marie-Tooth disease type 3Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000530.8. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MPZ | NM_000530.8 | MANE Select | c.448+1G>A | splice_donor intron | N/A | NP_000521.2 | |||
| MPZ | NM_001315491.2 | c.448+1G>A | splice_donor intron | N/A | NP_001302420.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MPZ | ENST00000533357.5 | TSL:1 MANE Select | c.448+1G>A | splice_donor intron | N/A | ENSP00000432943.1 | |||
| MPZ | ENST00000463290.5 | TSL:1 | n.448+1G>A | splice_donor intron | N/A | ENSP00000431538.1 | |||
| MPZ | ENST00000672602.2 | c.448+1G>A | splice_donor intron | N/A | ENSP00000500814.2 |
Frequencies
GnomAD3 genomes Cov.: 29
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461696Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 727166 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 29
ClinVar
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
The c.448+1G>A intronic variant results from a G to A substitution one nucleotide after coding exon 3 of the MPZ gene. Alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay._x000D_ _x000D_ for autosomal dominant MPZ-related Charcot-Marie-Tooth disease, type 1 and autosomal recessive MPZ-related Dejerine-Sottas Disease; however, its clinical significance for autosomal dominant MPZ-related neuropathic disorders is uncertain. This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This variant has been identified in at least one individual with an inherited neuropathy; however, clinical details were limited (DiVincenzo, 2014). This nucleotide position is highly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will weaken the native splice donor site and may result in the creation or strengthening of a novel splice donor site. Based on the available evidence, this alteration is classified as likely pathogenic.
Charcot-Marie-Tooth disease type 1B Pathogenic:1
Variant summary: MPZ c.448+1G>A is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing and loss of MPZ function. Several computational tools predict a significant impact on normal splicing: Four predict the variant abolishes a 5' splicing donor site. Four predict the variant creates a 5' donor site. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 6.2e-07 in 1613976 control chromosomes. c.448+1G>A has been reported in the literature in an study to screening for variants in genes associated with Charcot-Marie-Tooth disease type 1B without variant carrier data provided (DiVincenzo_2014). These report(s) do not provide unequivocal conclusions about association of the variant with Charcot-Marie-Tooth disease type 1B. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 25614874). ClinVar contains an entry for this variant (Variation ID: 2504290). Based on the evidence outlined above, the variant was classified as likely pathogenic.
not provided Pathogenic:1
Canonical splice site variant predicted to result in a null allele in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Truncating variants in this gene are considered pathogenic by a well-established clinical consortium and/or database (PMID: 25614874); This variant is associated with the following publications: (PMID: 33179255, 25614874)
Charcot-Marie-Tooth disease, type I Pathogenic:1
In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 2504290). Disruption of this splice site has been observed in individual(s) with Charcot-Marie-Tooth disease (PMID: 25614874). This variant is not present in population databases (gnomAD no frequency). This sequence change affects a donor splice site in intron 3 of the MPZ gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in MPZ are known to be pathogenic (PMID: 14711881).
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at